News

Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists.

A new approach could help to reduce a serious adverse effect related to chimeric antigen receptor (CAR) T-cell therapy.

Researchers have tested various treatment approaches to determine how effective they are in combatting certain types of cancer.

According to researchers using computer modeling and cell studies, more patients may be helped by a common class of targeted therapies than previously thought.

A Phase 2 clinical trial has shown that using sotorasib as a monotherapy can shrink tumors for patients who have KRAS^G12C-mutated colorectal tumors

A new trial has identified a combination of five existing drugs that keeps cancer at bay for longer in patients with highly aggressive bone marrow cancer.

Researchers have explored the therapeutic efficacy and side effects of a compound called AD732 in rat models. THey found that the compound possessed analgesic and anti-inflammatory properties, but with fewer side effects than standard non-steroidal painkillers.

Researchers have developed a platform that can rapidly screen thousands of compounds to identify potential antiviral drugs to treat coronaviruses.

A team of researchers has published an article in Nature Communications showing the potential of Find Cut-and-Transfer (FiCAT) technology as a state-of-the-art tool for gene writing to develop advanced therapies.

A new study has identified a protein in the central nervous system, known as mGlu1, as a potential target for novel treatments of schizophrenia.